Future4care announces a strategic partnership with Servier to accelerate innovation in Research & Development for the benefit of patients

Paris, December 16, 2026

Future4care announces a strategic partnership with Servier to accelerate innovation in Research & Development for the benefit of patients

Future4care, a European ecosystem dedicated to digital health, announces the signing of a strategic partnership with Servier, an independent international pharmaceutical group governed by a foundation. This partnership aims to drive innovation in healthcare, support collaborative R&D projects, and explore new uses of artificial intelligence in medical research.

This alliance is built on a shared ambition: bringing together complementary expertise—scientific, technological, industrial, and entrepreneurial—to foster the emergence of innovative, responsible, high-impact healthcare solutions.

A collaboration dedicated to R&D innovation

The objective of this collaboration is to develop structuring initiatives designed to:

·       Explore and integrate new uses of artificial intelligence across research activities, data analysis, modeling, and trial design;

·       Identify and support innovative startups, particularly in AI for healthcare, and launch proof-of-concepts (POCs) to assess high-potential solutions;

·       Strengthen collaborative R&D by facilitating interactions between the scientific teams of the Servier Paris-Saclay R&D Institute and Future4care’s digital health experts;

·       Actively participate in the life of the Future4care ecosystem, notably through specialized conferences, thematic workshops, expert groups, and flagship events, including the annual Future4care Demo Day.

A shared ambition: bringing science, technology, and innovation closer together to accelerate impact for patients

“We are convinced that together we move faster for patients. While AI and data technologies have become essential to accelerating therapeutic innovation, their success depends on collaboration between the academic, industrial, entrepreneurial, and healthcare worlds. This is why we are delighted to join this active, multidisciplinary ecosystem,” said Theo Lainé, Digital and Artificial Intelligence Director for R&D at Servier Group.

“We are delighted with this partnership with Servier, a committed laboratory. Future4care and Servier share common ambitions, and through this alliance we will work on initiatives serving science and progress, for a more inclusive healthcare for tomorrow” said Agnès de Leersnyder, CEO of Future4care.

About Future4care

Future4care is a European ecosystem bringing together multidisciplinary stakeholders dedicated to digital health. A joint venture founded in 2021 through the alliance of Capgemini, Generali, Orange, and Sanofi, Future4care brings together e-health players (large corporations, experts, healthcare professionals, startups, etc.) to create synergies and opportunities that accelerate progress in digital health.

Since its launch, Future4care has brought together industrial and institutional partners, as well as renowned figures from the scientific and academic communities, within a Scientific and Ethics Board.